Scope Fluidics Spolka Akcyjna (WAR:SCP) Total Equity: zł148.96 Mil (As of Mar. 2026)


WAR:SCP Scope Fluidics Spolka Akcyjna WAR:SCP
49 GF Score
Price zł120.00
GF Value zł129.86
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Scope Fluidics Spolka Akcyjna Total Equity?

Scope Fluidics Spolka Akcyjna WAR:SCP -1.32% 49 Total Equity is zł148.96 Mil as of Mar. 2026. GuruFocus rates WAR:SCP with a GF Score™ of 49/100 and a GF Value™ of zł129.86 (Fairly Valued). The stock has 4 warning signs investors should review.

Scope Fluidics Spolka Akcyjna's total equity for the quarter that ended in Mar. 2026 was zł148.96 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Scope Fluidics Spolka Akcyjna Total Equity Historical Data

* Premium members only.

The historical data trend for Scope Fluidics Spolka Akcyjna's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Scope Fluidics Spolka Akcyjna Total Equity Chart

Scope Fluidics Spolka Akcyjna Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.74 332.97 80.93 146.35 162.43

Scope Fluidics Spolka Akcyjna Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 135.35 126.80 115.43 162.43 148.96
WAR:SCP
49GF Score
Scope Fluidics Spolka Akcyjna WAR:SCP
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Scope Fluidics Spolka Akcyjna Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Scope Fluidics Spolka Akcyjna's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=195.935-33.504
=162.43

Scope Fluidics Spolka Akcyjna's Total Equity for the quarter that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=182.479-33.521
=148.96

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of zł148.96 Mil mean?
Scope Fluidics Spolka Akcyjna (WAR:SCP) has a Total Equity of zł148.96 Mil as of Mar. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Scope Fluidics Spolka Akcyjna and its competitors.
Is Scope Fluidics Spolka Akcyjna's Total Equity too high?
Scope Fluidics Spolka Akcyjna's current Total Equity is zł148.96 Mil. Overall, Scope Fluidics Spolka Akcyjna has a GF Score™ of 49/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Scope Fluidics Spolka Akcyjna's Total Equity compare to TMO and DHR?
Scope Fluidics Spolka Akcyjna's Total Equity of zł148.96 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Medical Diagnostics & Research company?
A good Total Equity depends on the Medical Diagnostics & Research industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Scope Fluidics Spolka Akcyjna and its competitors. Scope Fluidics Spolka Akcyjna's current Total Equity is zł148.96 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Scope Fluidics Spolka Akcyjna stock overvalued right now?
Based on GuruFocus' analysis, Scope Fluidics Spolka Akcyjna (WAR:SCP) is currently considered Fairly Valued. The stock's GF Value™ is zł129.86, compared to a current price of zł120.00 — trading 7.6% below its estimated fair value. The current Total Equity is zł148.96 Mil. Scope Fluidics Spolka Akcyjna's overall GF Score™ is 49/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Scope Fluidics Spolka Akcyjna (WAR:SCP), the current Total Equity is zł148.96 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Scope Fluidics Spolka Akcyjna (WAR:SCP) Overvalued in 2026?

Based on GuruFocus' analysis, Scope Fluidics Spolka Akcyjna stock appears to be undervalued. The current stock price of zł120.00 is trading 7.6% below its estimated GF Value™ of zł129.86. GuruFocus considers Scope Fluidics Spolka Akcyjna to be Fairly Valued.

Key valuation signals for WAR:SCP:

  • Total Equity: zł148.96 Mil
  • GF Value™: zł129.86 vs. price of zł120.00 (7.6% below fair value)
  • GF Score™: 49/100 with 4 warning signs

No single metric tells the full story. See the WAR:SCP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Scope Fluidics Spolka Akcyjna Business Description

Address Duchnicka 3, Build 16, Entrance A, Warsaw, POL, 01-796
Scope Fluidics Spolka Akcyjna focuses on global challenges in health to develop diagnostic and med tech solutions. The company combines the expertise in microfluidic technology with the awareness of the challenges in medical diagnostics. It provides prototyping support for diagnostic services.
49GF Score

Get the complete analysis for WAR:SCP

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł120.00
Price
zł129.86
GF Value